There are currently 22 active clinical trials seeking participants for Hepatitis C research studies. The states with the highest number of trials for Hepatitis C participants are California, Texas, New York and Florida.
HCV Test and Treat Utilizing Simplified HCV Patient Education
NCT05582681
Recruiting
The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
03/06/2024
Locations: Phoenix House, Long Island City, New York +2 locations
Conditions: Hepatitis C
Register for Updates
Tele-Harm Reduction
NCT05208697
Recruiting
The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/29/2024
Locations: Care Resource The SPOT, Fort Lauderdale, Florida +2 locations
Conditions: IV Drug Usage, HIV Infections, Hepatitis C
Register for Updates
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT01280825
Recruiting
The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: University of Chicago Medical Center, Chicago, Illinois
Conditions: Patients Undergoing Routine Health Care, Heart Diseases, Inflammatory Bowel Diseases, Autoimmune Disease, Inflammatory Disease, Blood Coagulation Disorders, Hepatitis C, Non-Metastatic Neoplasm
Register for Updates
Hepatitis C Treatment in Probation and Parole Office
NCT05413785
Recruiting
This prospective cohort study compares aims to determine the efficacy and effectiveness of telemedicine-supported on-site linkage to care and treatment in a community probation and parole office (P&P office) setting and compare the results with a historic control with referral to care. Research participants will be followed in the P&P office when they report to their officer during regularly scheduled appointments. Participants will receive treatment without having to travel to a specialist's of... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
01/05/2024
Locations: University of Kentucky, Lexington, Kentucky
Conditions: Hepatitis C, HCV
Register for Updates
Rural New England Health Study (Phase 2)
NCT05466331
Recruiting
This study will integrate mobile hepatitis C virus (HCV) testing and treatment with expanded syringe access in order to improve uptake of HCV testing and treatment, and reduce syringe sharing behavior in rural northern New England. The intervention aims to reach rural opioid injectors with HCV and to fill service gaps identified around access to syringe services and HCV testing and treatment, while limiting the burden on local partners. If effective, this mobile model of HCV telehealth integrate... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/28/2023
Locations: Mobile Study Van, Keene, New Hampshire +2 locations
Conditions: Hepatitis C, Opioid Use Disorder, IV Drug Usage
Register for Updates
Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants
NCT04701437
Recruiting
The overarching goal of this study is to develop a peer-based care coordination intervention for individuals with HCV who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the existing barriers and facilitators of HCV treatment initiation, HCV treatment completion, and sustained virologic response among individuals recently released from a U.S. jail or prisons in a randomized control trial. This study will assess the... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/09/2023
Locations: Prisma Health-Upstate, Greenville, South Carolina
Conditions: Hepatitis C
Register for Updates
The Hepatitis C Transplant Collaborative
NCT04493385
Recruiting
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/25/2023
Locations: Baylor Scott & White Health Research Institute, Dallas, Texas
Conditions: Transplant; Failure, Heart, Hepatitis C
Register for Updates
Transplanting Hepatitis C Positive Organs
NCT03086044
Recruiting
This is an open-label, pilot safety and efficacy trial for adults who are active on the heart, lung, or kidney transplantation lists and are eligible to receive an organ from an increased risk donor who has evidence of active or prior hepatitis C infection (HCV).
Gender:
All
Ages:
18 years and above
Trial Updated:
10/10/2022
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Hepatitis C, Awaiting Organ Transplant
Register for Updates
Outcomes Mandate National Integration With Cannabis as Medicine
NCT03944447
Recruiting
This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.
Gender:
All
Ages:
7 years and above
Trial Updated:
05/29/2022
Locations: OMNI Medical Services, Boca Raton, Florida +16 locations
Conditions: Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury, Chronic Pain Due to Trauma, Fibromyalgia, Seizures, Hepatitis C, Cancer, Crohn Disease, HIV/AIDS, Multiple Sclerosis, Traumatic Brain Injury, Sickle Cell Disease, Post Traumatic Stress Disorder, Tourette Syndrome, Ulcerative Colitis, Glaucoma, Epilepsy, Inflammatory Bowel Diseases, Parkinson Disease, Amyotrophic Lateral Sclerosis, Chronic Traumatic Encephalopathy, Anxiety, Depression, Insomnia, Autism, Opioid-use Disorder, Bipolar Disorder, Covid19, SARS-CoV Infection, COVID-19, Corona Virus Infection, Coronavirus
Register for Updates
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
NCT05368974
Recruiting
Clinical interventions to reduce the risk of vertical transmission of hepatitis C virus (HCV) infection from mother to infant are highly limited. Direct-acting antiviral (DAA) medications have demonstrated excellent safety and efficacy in non-pregnant individuals, but there is a lack of data regarding the safety of these medications in pregnant women and the effectiveness of these medications in reducing mother-to-child transmission. Therefore, although HCV screening during pregnancy is now reco... Read More
Gender:
All
Ages:
All
Trial Updated:
05/06/2022
Locations: The Taskforce for Global Health, Atlanta, Georgia
Conditions: Hepatitis C
Register for Updates